Denver-based Healthpeak Properties is slicing off its senior-housing business into a new publicly traded company, Janus Living, and marching it toward an IPO. The carve-out includes 34 communities with roughly 10,422 units spread across 10 states, and Healthpeak says it plans to keep meaningful economic skin in the game through a post-IPO ownership stake. Company leadership argues the move will free up cash to plow into higher-growth life-science and outpatient medical real estate.
The spinoff surfaced in local business reporting and company investor decks. According to the Denver Business Journal, Healthpeak is shifting the senior-housing assets into a separate vehicle, while materials from Healthpeak outline a portfolio concentrated in a handful of key retirement markets.
In a press release via Healthpeak, the company said Janus Living has publicly filed a registration statement on Form S-11 with the U.S. Securities and Exchange Commission as of Feb. 27 and intends to list its Class A-1 shares on the New York Stock Exchange under the ticker symbol "JAN." The filing names BofA Securities and J.P. Morgan as lead book-running managers and notes that the offering is still subject to SEC review and the usual closing conditions.
IPO Terms And Size
Renaissance Capital reports that Janus Living has set terms for an IPO of roughly $703 million, with a preliminary price range of $18 to $20 per share and about 37 million shares on offer. Where the deal prices and how much stock ultimately trades will determine how much capital Healthpeak can recycle while still holding on to an economic stake in the new REIT.
Why Healthpeak Is Spinning It Off
Healthpeak has pitched the transaction as a way to "unlock value" in a business segment it says the market is discounting, while raising cash for its preferred growth engines in life science and outpatient medical properties. As reported by Nasdaq, the company is targeting roughly $1 billion of proceeds from a mix of asset sales, recapitalizations and loan repayments, and it has a senior-housing pipeline of about $675 million already under letters of intent.
What Janus Living Will Own
According to investor materials from Healthpeak, the Janus Living portfolio is fully RIDEA-structured and tilted toward high-demand retirement destinations. Roughly 69% of its units sit in Florida and Texas, with top markets including Tampa and Houston. The same materials point to about 592 units tied to the Denver area, giving the new company a notable local footprint even as it prepares for a New York listing.
Regulatory And Next Steps
Healthpeak has repeatedly cautioned that the IPO cannot move forward until the SEC declares the registration statement effective, and that there is no guarantee the offering will hit the market on the current timeline. The company has emphasized that the deal remains subject to market conditions, regulatory approvals and other standard closing requirements.
For Denver investors and real estate watchers, the key markers from here are the SEC review, the final pricing and whether Healthpeak's capital-recycling strategy actually speeds up new acquisitions in outpatient and lab properties. The IPO calendar at Renaissance Capital and the preliminary prospectus will offer the next public clues about how the Janus Living rollout is playing on Wall Street.
